Acetylsalicylic acid Not Yet Recruiting Phase 4 Trials for Peripheral Artery Disease (PAD) / Coronary Artery Disease Other

IndicationsStatusPurposePhase
Not Yet RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT04059679Synergistic Influence of Rivaroxaban on Inflammation and Coagulation Biomarkers in Patients With CAD and PAD on Aspirin Therapy